Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 135,590 | 119,027 | 130,974 | 117,484 | 75,505 |
| Cost of Goods | 35,248 | 31,349 | 35,298 | 29,993 | 22,305 |
| Gross Profit | 100,342 | 87,678 | 95,676 | 87,491 | 53,200 |
| Operating Expenses | 65,747 | 68,590 | 77,191 | 70,864 | 60,652 |
| Operating Income | 34,843 | 19,437 | 18,783 | 17,620 | -7,147 |
| Interest Expense | 7,023 | 6,971 | 7,061 | 7,132 | 5,456 |
| Other Income | -2,172 | 258 | 971 | -4,338 | 5,292 |
| Pre-tax Income | 25,648 | 12,724 | 12,693 | 6,150 | -7,311 |
| Income Tax | 6,567 | 2,355 | -1,821 | -123,969 | -42 |
| Net Income Continuous | 19,081 | 10,369 | 14,514 | 130,119 | -7,269 |
| Net Income | $19,081 | $10,369 | $14,514 | $130,119 | $-7,269 |
| EPS Basic Total Ops | 0.43 | 0.24 | 0.36 | 3.03 | -0.17 |
| EPS Basic Continuous Ops | 0.43 | 0.24 | 0.36 | 3.03 | -0.17 |
| EPS Diluted Total Ops | 0.42 | 0.23 | 0.37 | 2.94 | -0.17 |
| EPS Diluted Continuous Ops | 0.42 | 0.23 | 0.37 | 2.94 | -0.17 |
| EBITDA(a) | $46,143 | $30,596 | $30,058 | $28,716 | $1,946 |